company background image
XRAY logo

DENTSPLY SIRONA NasdaqGS:XRAY Voorraadrapport

Laatste prijs

US$18.52

Marktkapitalisatie

US$3.8b

7D

6.7%

1Y

-40.9%

Bijgewerkt

20 Nov, 2024

Gegevens

Financiële gegevens bedrijf +

DENTSPLY SIRONA Inc.

NasdaqGS:XRAY Voorraadrapport

Marktkapitalisatie: US$3.8b

XRAY Overzicht aandelen

DENTSPLY SIRONA Inc. produceert en verkoopt wereldwijd verschillende tandheelkundige producten en technologieën. Meer informatie

DENTSPLY SIRONA Inc. Concurrenten

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor DENTSPLY SIRONA
Historische aandelenkoersen
Huidige aandelenkoersUS$18.52
52 Week HoogtepuntUS$37.60
52 Week LaagUS$17.21
Bèta1.03
11 maand verandering-24.19%
3 maanden verandering-23.28%
1 Jaar Verandering-40.94%
33 jaar verandering-63.87%
5 jaar verandering-67.57%
Verandering sinds IPO2,553.61%

Recent nieuws en updates

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough

Nov 11
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough

DENTSPLY SIRONA (NASDAQ:XRAY) Hasn't Managed To Accelerate Its Returns

Oct 13
DENTSPLY SIRONA (NASDAQ:XRAY) Hasn't Managed To Accelerate Its Returns

Recent updates

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough

Nov 11
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough

DENTSPLY SIRONA (NASDAQ:XRAY) Hasn't Managed To Accelerate Its Returns

Oct 13
DENTSPLY SIRONA (NASDAQ:XRAY) Hasn't Managed To Accelerate Its Returns

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Looks Inexpensive But Perhaps Not Attractive Enough

Sep 25
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Looks Inexpensive But Perhaps Not Attractive Enough

Is It Time To Consider Buying DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

Sep 05
Is It Time To Consider Buying DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

Is There An Opportunity With DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) 21% Undervaluation?

Aug 18
Is There An Opportunity With DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) 21% Undervaluation?

Returns On Capital At DENTSPLY SIRONA (NASDAQ:XRAY) Have Hit The Brakes

Jul 11
Returns On Capital At DENTSPLY SIRONA (NASDAQ:XRAY) Have Hit The Brakes

A Tough Macro Environment Makes Dentsply Sirona's Turnaround Even Harder

Jul 02

Insufficient Growth At DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Hampers Share Price

Jun 11
Insufficient Growth At DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Hampers Share Price

We Think DENTSPLY SIRONA (NASDAQ:XRAY) Can Stay On Top Of Its Debt

May 24
We Think DENTSPLY SIRONA (NASDAQ:XRAY) Can Stay On Top Of Its Debt

Dentsply Sirona: I'm Buying The Pullback In This Medtech Leader

Apr 24

Are Investors Undervaluing DENTSPLY SIRONA Inc. (NASDAQ:XRAY) By 47%?

Apr 22
Are Investors Undervaluing DENTSPLY SIRONA Inc. (NASDAQ:XRAY) By 47%?

There's No Escaping DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Muted Revenues

Mar 10
There's No Escaping DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Muted Revenues

Here's Why DENTSPLY SIRONA (NASDAQ:XRAY) Has A Meaningful Debt Burden

Feb 16
Here's Why DENTSPLY SIRONA (NASDAQ:XRAY) Has A Meaningful Debt Burden

DENTSPLY SIRONA (NASDAQ:XRAY) Has More To Do To Multiply In Value Going Forward

Jan 29
DENTSPLY SIRONA (NASDAQ:XRAY) Has More To Do To Multiply In Value Going Forward

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Could Be 28% Below Their Intrinsic Value Estimate

Jan 11
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Could Be 28% Below Their Intrinsic Value Estimate

Is It Too Late To Consider Buying DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

Nov 25
Is It Too Late To Consider Buying DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

These 4 Measures Indicate That DENTSPLY SIRONA (NASDAQ:XRAY) Is Using Debt Extensively

Nov 06
These 4 Measures Indicate That DENTSPLY SIRONA (NASDAQ:XRAY) Is Using Debt Extensively

Returns On Capital At DENTSPLY SIRONA (NASDAQ:XRAY) Paint A Concerning Picture

Oct 15
Returns On Capital At DENTSPLY SIRONA (NASDAQ:XRAY) Paint A Concerning Picture

An Intrinsic Calculation For DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Suggests It's 46% Undervalued

Sep 18
An Intrinsic Calculation For DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Suggests It's 46% Undervalued

DENTSPLY SIRONA (NASDAQ:XRAY) Has A Pretty Healthy Balance Sheet

Jul 31
DENTSPLY SIRONA (NASDAQ:XRAY) Has A Pretty Healthy Balance Sheet

The Returns At DENTSPLY SIRONA (NASDAQ:XRAY) Aren't Growing

Jul 09
The Returns At DENTSPLY SIRONA (NASDAQ:XRAY) Aren't Growing

A Look At The Fair Value Of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Jun 20
A Look At The Fair Value Of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

When Should You Buy DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

Jun 02
When Should You Buy DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

Investors Don't See Light At End Of DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Tunnel

May 15
Investors Don't See Light At End Of DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Tunnel

The Returns At DENTSPLY SIRONA (NASDAQ:XRAY) Aren't Growing

Apr 05
The Returns At DENTSPLY SIRONA (NASDAQ:XRAY) Aren't Growing

Is DENTSPLY SIRONA (NASDAQ:XRAY) Using Too Much Debt?

Mar 07
Is DENTSPLY SIRONA (NASDAQ:XRAY) Using Too Much Debt?

We Think DENTSPLY SIRONA (NASDAQ:XRAY) Can Stay On Top Of Its Debt

Nov 09
We Think DENTSPLY SIRONA (NASDAQ:XRAY) Can Stay On Top Of Its Debt

Dentsply Sirona names Glenn Coleman as new CFO

Sep 22

Dentsply Sirona hires Simon Campion as president, CEO

Aug 25

Dentsply Sirona receives noncompliance notice from Nasdaq

Aug 16

Dentsply Sirona: Weakening Fundamentals Outweigh 'Defensives' Argument

Jul 18

Rendement voor aandeelhouders

XRAYUS Medical EquipmentUS Markt
7D6.7%-0.4%-1.0%
1Y-40.9%20.3%30.3%

Rendement versus industrie: XRAY presteerde slechter dan de US Medical Equipment -sector, die het afgelopen jaar een rendement van 20.3 % opleverde.

Rendement versus markt: XRAY presteerde slechter dan US Market, dat het afgelopen jaar een rendement van 30.3 % opleverde.

Prijsvolatiliteit

Is XRAY's price volatile compared to industry and market?
XRAY volatility
XRAY Average Weekly Movement8.9%
Medical Equipment Industry Average Movement8.2%
Market Average Movement6.2%
10% most volatile stocks in US Market15.7%
10% least volatile stocks in US Market3.1%

Stabiele aandelenkoers: XRAY heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 9% ) van XRAY is het afgelopen jaar stabiel geweest.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
187715,000Simon Campionwww.dentsplysirona.com

DENTSPLY SIRONA Inc. produceert en verkoopt wereldwijd verschillende tandheelkundige producten en technologieën. Het bedrijf is actief in vier segmenten: Connected Technology Solutions, Essential Dental Solutions, Orthodontische en Implantaatoplossingen en Wellspect Healthcare. Het bedrijf biedt tandheelkundige apparatuur aan, waaronder beeldvormingsapparatuur, gemotoriseerde tandheelkundige handstukken, behandelcentra, andere instrumenten, amalgamatoren, mengmachines en porseleinovens; en tandheelkundige CAD/CAM-technologieën ter ondersteuning van tandheelkundige restauraties, zoals intra-orale scanners, 3D-printers, frezen, andere software en diensten, en een full-chairside economische restauratie van esthetische keramische tandheelkunde, evenals DS Core, het cloud-gebaseerde platform.

DENTSPLY SIRONA Inc. Samenvatting

Hoe verhouden de winst en inkomsten van DENTSPLY SIRONA zich tot de beurswaarde?
XRAY fundamentele statistieken
MarktkapitalisatieUS$3.75b
Inkomsten(TTM)-US$413.00m
Inkomsten(TTM)US$3.90b

0.9x

P/S-verhouding

-8.9x

Koers/Winstverhouding

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
XRAY resultatenrekening (TTM)
InkomstenUS$3.90b
Kosten van inkomstenUS$1.87b
BrutowinstUS$2.04b
Overige uitgavenUS$2.45b
Inkomsten-US$413.00m

Laatst gerapporteerde inkomsten

Sep 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)-2.08
Brutomarge52.18%
Nettowinstmarge-10.59%
Schuld/Eigen Vermogen Verhouding89.7%

Hoe presteerde XRAY op de lange termijn?

Bekijk historische prestaties en vergelijking

Dividenden

3.5%

Huidig dividendrendement

-31%

Uitbetalingsratio